Flagship Creates Clinical Trials and Regulatory Affairs Group

Flagship Biosciences created a Clinical Trials and Regulatory Affairs Group and partners with DOCRO, Inc., an industry leader for IVD clinical trials and regulatory affairs, to bring image analysis based Companion Diagnostics (CDx) into the clinical market. Westminster, CO – January 19th, 2016 – Flagship Biosciences has created a Clinical Trials and Regulatory Affairs group and partners […]

Read More

Quality Management System for the development of Medical Device Software

Flagship Biosciences establishes a Quality Management System (QMS) for the development of medical device software to bring image analysis based Companion Diagnostics (CDx) into the clinical market. Westminster, CO – October 27, 2015 – Flagship Biosciences’ Software Development Department has established a Quality Management System (QMS) for the development of medical device software in compliance […]

Read More

Flagship launches new website to highlight areas of clinical focus

Denver, CO – Oct 20, 2015 – Flagship Biosciences, the largest tissue image analysis provider for the drug development industry, is pleased to announce a website redesign, which highlights our advanced technology and clinical readiness needed to support image analysis based companion diagnostic strategies for the pharmaceutical industry. Flagship’s growth has been accelerated by the […]

Read More

Dr. Dan Rudmann Joins Flagship Biosciences as VP of Program Development

Westminster, CO – Sept 16, 2015 – Flagship Biosciences continues to expand its leadership position in pathology-focused tissue image analysis with the addition of Dr. Dan Rudmann as Vice President of Program Development. Dr. Rudmann comes to Flagship with more than 18 years of experience in drug development and pathology, most recently as Global Head […]

Read More

Datacolor and Flagship Biosciences to Integrate CHROMACAL Color Calibration into TALIS Digital Imaging Platform

Lawrenceville, NJ – September 9, 2015 – Datacolor® and Flagship Biosciences, Inc. (Westminster, CO) have announced a new collaboration to integrate Datacolor CHROMACAL™ color calibration technology into Flagship’s proprietary digital imaging platform TALIS™ (Tissue Analysis Laboratory Information System). The collaboration is significant because it combines the technologies of two industry leaders to establish a new […]

Read More

Dr. Cris Luengo joins Flagship as Director of Image Analysis

Top image analysis expert Dr. Cris Luengo joins Flagship Biosciences as Director of Image Analysis Westminster, CO – July 20, 2015 – – Flagship Biosciences continues to expand its leadership position in tissue image analysis with the addition of Dr. Cris Luengo as Director of Image Analysis. Dr. Luengo is an internationally recognized expert in […]

Read More

Flagship Biosciences presents tumor immunology research at AACR meeting

Flagship Biosciences gives three posters and one oral presentation at AACR meeting Westminster, CO – April 20, 2015 – Flagship Biosciences will be presenting its industry-leading research in tissue image analysis and tumor immunology at the American Association of Cancer Research (AACR) annual meeting in Philadelphia, Pennsylvania. Flagship’s technology is developed in partnership with pharmaceutical […]

Read More

Flagship Biosciences customizes assay development and tissue image analysis for Advanced Cell Diagnostics RNAscope platform

Flagship Biosciences and Advanced Cell Diagnostics collaborate to develop quantitative RNAscope® assays for pharmaceutical clinical trials in the CLIA environment Westminster, CO – April 15, 2015 – Flagship Biosciences, the leading service provider of tissue image analysis solutions, announced today the utilization of its wet assay development and image analysis quantification capabilities for RNAscope® RNA […]

Read More

Flagship Biosciences reaches milestone with “fit-for-purpose” digital pathology services

Flagship Biosciences’ completes its 400th study with tissue image analysis, and fit-for-purpose IHC and ISH assay development Westminster, CO – April 5, 2015 – Since 2009, Flagship Biosciences has grown to become recognized as the clear industry leader in the delivery of precision pathology reports quantifying a given endpoint in tissue studies. These reports are […]

Read More

Flagship announces relocation and consolidation of offices and laboratory

“Our new location will allow us to continue to grow to meet the demand for our services, and improve logistics in all phases of our operations.” Westminster, CO – Aug, 26, 2014 – Flagship Biosciences LLC, a leading provider of tissue image analysis services to the pharmaceutical and medical device industries, has announced a laboratory […]

Read More